ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Regional Fatty Acid Metabolism in Humans

This study is currently recruiting patients.

Sponsored by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

There are several studies looking at how dietary fat is metabolized by humans. We give special meals and collect blood, breath, urine and fat samples to study how people burn and store dietary fat.

Condition
Diabetes Mellitus, Type 2

MedlinePlus related topics:  Diabetes

Study Type: Observational
Study Design: Screening, Cross-Sectional, Defined Population, Prospective Study

Further Study Details: 

Expected Total Enrollment:  150

Study start: September 1999;  Study completion: December 2005

Eligibility

Ages Eligible for Study:  18 Years   -   50 Years,  Genders Eligible for Study:  Both

Accepts Healthy Volunteers

Criteria

Inclusion Criteria: BMI<25 Lean, sedentary with family histor of DM2 and Lean, sedentary without family history of DM2 and Lean, active without family history of DM2. Non-smokers.

Exclusion Criteria: Known systemic illnes, cardiac and vascular disease and BP> 160/95 on HTN meds. Medications that affect fat metabolism. We do not pay for travel expenses.


Location and Contact Information


Minnesota
      Mayo Clinic, Rochester,  Minnesota,  55905,  United States; Recruiting
Michael D Jensen, MD  507-284-2511    jensen@mayo.edu 
Carol Siverling, RN  5072842511    siverling.carol@mayo.edu 
Susi Votruba, PhD,  Sub-Investigator

More Information

Study ID Numbers:  RFAMH
Record last reviewed:  October 2004
Record first received:  September 10, 2003
ClinicalTrials.gov Identifier:  NCT00068887
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2004-10-27
line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act